Adults: Treatment of Erosive Gastroesophageal Reflux Disease: 50 mg once daily for 4 weeks.
For patients who do not heal or have persistent symptoms after 4 weeks, an additional 4-week treatment maybe considered.
Treatment of Non-Erosive Gastroesophageal Reflux Disease: 50 mg once daily for 4 weeks.
Treatment of Gastric Ulcer: 50 mg once daily for 8 weeks.
Eradication of H. pylori concurrently given with appropriate antibiotic therapy treatment in patients with peptic ulcer and/or chronic atrophic gastritis: Patients with H. pylori infection should be treated with eradication therapy. K-CAB 50 mg, clarithromycin 500 mg, and amoxicillin 1 g are orally administered twice daily for 7 days.
K-CAB can be taken without regard to food.
Route of Administration: Oral route.